Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer.
about
Cell-cycle and suppressor proteins expression in uterine cervix in HIV/HPV co-infection: comparative study by tissue micro-array (TMA).Psychosocial functioning and vascular endothelial growth factor in patients with head and neck cancer.Down-regulated nucleoside diphosphate kinase nm23-H1 expression is unrelated to high-risk human papillomavirus but associated with progression of cervical intraepithelial neoplasia and unfavourable prognosis in cervical cancer.Immunohistochemical Expression of VEGF and Podoplanin in Uterine Cervical Squamous Intraepithelial Lesions.Increased expression of RRM2 by human papillomavirus E7 oncoprotein promotes angiogenesis in cervical cancerCytokines as potential tumour markers.Cigarette smoke stimulates VEGF-C expression in cervical intraepithelial neoplasia (CIN) 1 and 2 lesions.Human telomerase reverse transcriptase regulates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer cells.Vascular endothelial growth factor C expression is closely correlated with lymph node recurrence and poor prognosis in patients with early stage cervical cancer.Apatinib, a novel tyrosine kinase inhibitor, suppresses tumor growth in cervical cancer and synergizes with Paclitaxel.
P2860
Q33374407-5E171C79-3904-49FE-8F15-645FE9ED3F55Q33905994-A555AA77-0FE4-4A6E-9F53-623FB5E95EA3Q35774362-71A6FE21-F027-4437-8A83-4A186660C5CFQ36974039-AEDDBA27-24C4-483F-AD9E-6FBC2D3495BEQ37594412-17367771-3202-4640-B398-9448E86AFA68Q38089767-31A02845-5C7A-4025-9CFF-AFC44D48DA5AQ38408018-0B41315D-5435-44A0-8422-DA6C84943F6BQ38864853-48F29795-EA91-4402-A187-A364F7EAA685Q45212474-DB749E79-57A2-46CB-9470-FB60AFEEC25AQ54976603-BAC2AD60-4DAD-4108-9D5B-A897674172CE
P2860
Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Aberrant expression of VEGF-C ...... prognosis of cervical cancer.
@ast
Aberrant expression of VEGF-C ...... prognosis of cervical cancer.
@en
type
label
Aberrant expression of VEGF-C ...... prognosis of cervical cancer.
@ast
Aberrant expression of VEGF-C ...... prognosis of cervical cancer.
@en
prefLabel
Aberrant expression of VEGF-C ...... prognosis of cervical cancer.
@ast
Aberrant expression of VEGF-C ...... prognosis of cervical cancer.
@en
P2093
P2860
P356
P1476
Aberrant expression of VEGF-C ...... r prognosis of cervical cancer
@en
P2093
A Benedetto
D Bonifacio
HPV-Pathogen ISS Study Group
K Syrjänen
L Di Bonito
P2860
P356
10.1136/JCP.2005.026922
P407
P577
2006-01-01T00:00:00Z